Eli Lilly & Co.

NYS : LLY
Pharmaceuticals
Indianapolis IN
IW Best50N/A
2012 Revenue (US$ Millions)$22,603
2011 Revenue (US$ Millions)$24,287
Revenue Growth (%)-6.93%
Net Income (US$ Millions)$4,089
Common Shares Outstanding (Millions)$1,144
Earnings Per Share (US$)$3.66
Total Equity (US$ Millions)$14,765
Profit Growth (%)-5.96
Profit Margin (%)18.09%
Return On Equity (%)30.19%
Long Term Debt (US$ Millions)$5,519
Debt To Equity Ratio (%)0.37%
Market Capitalization (US$ Millions)$56,404
Total Assets (US$ Millions)$34,399
Return on Assets (%)12.15
Current Assets (US$ Millions)$13,039
Inventories (US$ Millions)$2,644
Current Liabilities (US$ Millions)$8,390
Cost of Goods Sold (US$ Millions)$4,797
Asset Turnover0.66
Inventory Turnover1.94